654 related articles for article (PubMed ID: 22524795)
21. Determinants of exercise capacity in obese and non-obese COPD patients.
Rodríguez DA; Garcia-Aymerich J; Valera JL; Sauleda J; Togores B; Galdiz JB; Gea J; Orozco-Levi M; Ferrer A; Gomez FP; Barberà JA; Serra I; Antó JM; Roca J;
Respir Med; 2014 May; 108(5):745-51. PubMed ID: 24565602
[TBL] [Abstract][Full Text] [Related]
22. Physiologic responses during the six minute walk test in obese and non-obese COPD patients.
Bautista J; Ehsan M; Normandin E; Zuwallack R; Lahiri B
Respir Med; 2011 Aug; 105(8):1189-94. PubMed ID: 21414763
[TBL] [Abstract][Full Text] [Related]
23. Cardiopulmonary responses to treadmill and cycle ergometry exercise in patients with peripheral vascular disease.
Tuner SL; Easton C; Wilson J; Byrne DS; Rogers P; Kilduff LP; Kingsmore DB; Pitsiladis YP
J Vasc Surg; 2008 Jan; 47(1):123-30. PubMed ID: 18178463
[TBL] [Abstract][Full Text] [Related]
24. Association of six-minute walk distance (6MWD) with resting pulmonary function in patients with chronic obstructive pulmonary disease (COPD).
Fujimoto H; Asai K; Watanabe T; Kanazawa H; Hirata K
Osaka City Med J; 2011 Jun; 57(1):21-9. PubMed ID: 22106764
[TBL] [Abstract][Full Text] [Related]
25. Predicting oxygen uptake for men and women with moderate to severe chronic obstructive pulmonary disease.
Carter R; Holiday DB; Stocks J; Grothues C; Tiep B
Arch Phys Med Rehabil; 2003 Aug; 84(8):1158-64. PubMed ID: 12917855
[TBL] [Abstract][Full Text] [Related]
26. Use of 6-min and 12-min walking test for assessing the efficacy of formoterol in COPD.
Cazzola M; Biscione GL; Pasqua F; Crigna G; Appodia M; Cardaci V; Ferri L
Respir Med; 2008 Oct; 102(10):1425-30. PubMed ID: 18621519
[TBL] [Abstract][Full Text] [Related]
27. Estimating maximum work rate during incremental cycle ergometry testing from six-minute walk distance in patients with chronic obstructive pulmonary disease.
Hill K; Jenkins SC; Cecins N; Philippe DL; Hillman DR; Eastwood PR
Arch Phys Med Rehabil; 2008 Sep; 89(9):1782-7. PubMed ID: 18760164
[TBL] [Abstract][Full Text] [Related]
28. Diagnostic value of the six-minute walk test (6MWT) in grown-up congenital heart disease (GUCH): Comparison with clinical status and functional exercise capacity.
Kehmeier ES; Sommer MH; Galonska A; Zeus T; Verde P; Kelm M
Int J Cardiol; 2016 Jan; 203():90-7. PubMed ID: 26498869
[TBL] [Abstract][Full Text] [Related]
29. Cardiopulmonary and gas-exchange responses during the six-minute walk test in patients with chronic obstructive pulmonary disease.
van Gestel AJ; Baty F; Rausch-Osthof AK; Brutsche MH
Respiration; 2014; 88(4):307-14. PubMed ID: 25227115
[TBL] [Abstract][Full Text] [Related]
30. Impact of anaemia on lung function and exercise capacity in patients with stable severe chronic obstructive pulmonary disease.
Guo J; Zheng C; Xiao Q; Gong S; Zhao Q; Wang L; He J; Yang W; Shi X; Sun X; Liu J
BMJ Open; 2015 Oct; 5(10):e008295. PubMed ID: 26450428
[TBL] [Abstract][Full Text] [Related]
31. A symptom-limited incremental step test determines maximum physiological responses in patients with chronic obstructive pulmonary disease.
Dal Corso S; de Camargo AA; Izbicki M; Malaguti C; Nery LE
Respir Med; 2013 Dec; 107(12):1993-9. PubMed ID: 23863809
[TBL] [Abstract][Full Text] [Related]
32. Plasma ammonia response to incremental cycling and walking tests in COPD.
Calvert LD; Steiner MC; Morgan MD; Singh SJ
Respir Med; 2010 May; 104(5):675-81. PubMed ID: 20004089
[TBL] [Abstract][Full Text] [Related]
33. Estimating exercise capacity from walking tests in elderly individuals with stable coronary artery disease.
Mandic S; Walker R; Stevens E; Nye ER; Body D; Barclay L; Williams MJ
Disabil Rehabil; 2013; 35(22):1853-8. PubMed ID: 23600709
[TBL] [Abstract][Full Text] [Related]
34. Replacement of the 6-min walk test with maximal oxygen consumption in the BODE Index applied to patients with COPD: an equivalency study.
Cardoso F; Tufanin AT; Colucci M; Nascimento O; Jardim JR
Chest; 2007 Aug; 132(2):477-82. PubMed ID: 17505032
[TBL] [Abstract][Full Text] [Related]
35. Does exercise test modality influence dyspnoea perception in obese patients with COPD?
Ciavaglia CE; Guenette JA; Ora J; Webb KA; Neder JA; O'Donnell DE
Eur Respir J; 2014 Jun; 43(6):1621-30. PubMed ID: 24311769
[TBL] [Abstract][Full Text] [Related]
36. [Effect of dynamic hyperinflation on exertional dyspnea, exercise performance and quality of life in COPD].
Ozgur ES; Atis S; Kanik A
Tuberk Toraks; 2008; 56(3):296-303. PubMed ID: 18932031
[TBL] [Abstract][Full Text] [Related]
37. Comparing cardiopulmonary exercise testing in severe COPD patients with and without pulmonary hypertension.
Thirapatarapong W; Armstrong HF; Bartels MN
Heart Lung Circ; 2014 Sep; 23(9):833-40. PubMed ID: 24793962
[TBL] [Abstract][Full Text] [Related]
38. Which field walking test should be used to assess functional exercise capacity in lung cancer? An observational study.
Granger CL; Denehy L; Parry SM; Martin J; Dimitriadis T; Sorohan M; Irving L
BMC Pulm Med; 2015 Aug; 15():89. PubMed ID: 26264470
[TBL] [Abstract][Full Text] [Related]
39. Inspiratory capacity, dynamic hyperinflation, breathlessness, and exercise performance during the 6-minute-walk test in chronic obstructive pulmonary disease.
Marin JM; Carrizo SJ; Gascon M; Sanchez A; Gallego B; Celli BR
Am J Respir Crit Care Med; 2001 May; 163(6):1395-9. PubMed ID: 11371407
[TBL] [Abstract][Full Text] [Related]
40. Impaired carbon monoxide diffusing capacity is the strongest predictor of exercise intolerance in COPD.
Farkhooy A; Janson C; Arnardóttir RH; Malinovschi A; Emtner M; Hedenström H
COPD; 2013 Apr; 10(2):180-5. PubMed ID: 23547629
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
